Loading...
Inhibition of autophagy flux by sertraline attenuates TRAIL resistance in lung cancer via death receptor 5 upregulation
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a potential target for cancer therapy, owing to its ability to selectively kill cancer cells without causing significant toxicity to normal cells. However, due to the lack of death receptor expression, cancer cells can become highly...
Na minha lista:
| Udgivet i: | Int J Mol Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7307864/ https://ncbi.nlm.nih.gov/pubmed/32626921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2020.4635 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|